Nasrin Motamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nasrin Motamed has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Ahmadreza Jamshidi
Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications- Ehsan Arefian
Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
2 shared publications Elham Karimizadeh
Department of Cell and Molecular Biology, School of biology, College of Science, University of Tehran, P.O. Box 141556455, Tehran, Iran
2 shared publications- Mahdi Mahmoudi
Rheumatology Research center, Tehran University of medical sciences, Tehran, Iran
2 shared publications Maryam Shahhoseini
Affiliations Department of Cellular and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran, Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
2 shared publicationsSaeideh Jafarinejad-Farsangi
Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran
2 shared publications
Latest Publications
- 31 March 2026
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (5) , 104325
Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a
- 31 March 2026
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (5) , 104325
Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a
- Open Access
- 21 January 2026
- Published by Springer Nature in Research Square
The miR-142-5p overexpression induces cell cycle arrest and apoptosis by targeting genes MCL1 and CDK6 in pancreatic cancer cells; AsPC-1, PANC-1
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers worldwide, and there is an urgent demand for novel therapeutic approaches. MicroRNAs (miRNAs) are promising molecules to regulate gene expression in PDAC. This study investigates the role of miR-142 in cell proliferation and apoptosis in two cell lines, AsPC-1 and PANC-1, with a focus on gene expression changes of selected genes induced by overexpression of miR-142-5p. The molecular features in PDAC were evaluated using KEGG, and significant genes in cell cycle regulation, apoptosis, and PI3k/AKT pathway were selected (CDK6, MCL1, PIK3CA). DIANA-microT-CDS and TargetScan version 7.1 were used to select miR-142 based on prediction score. Selected genes did not contain any predicted seed site matches for the 3p arm of miR-142. miR-142 was overexpressed by transfecting a vector carrying the pre-miRNA-142 sequence into two pancreatic cancer cell lines. Overexpression of miR-142 and its effect on downregulating target genes was confirmed by quantitative real-time PCR (RT-qPCR). Predicted target genes (CDK6 and MCL1) were evaluated by the Luciferase assay. Apoptosis and cell cycle arrest were performed to analyze cell proliferation and cell viability under the effect of miR-142. Our results showed that miR-142-5p reduced the expression of its target genes. Cell cycle arrest was increased in both cell lines, while apoptosis increased in PANC-1. Overall, miR-142 may function as a tumor suppressor in PDAC by downregulating the overexpressed cancer-related genes and suppressing proliferation in AsPC-1 and PANC1.
- 21 January 2026
- Published by Springer Nature in Research Square
Open AccessThe miR-142-5p overexpression induces cell cycle arrest and apoptosis by targeting genes MCL1 and CDK6 in pancreatic cancer cells; AsPC-1, PANC-1
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers worldwide, and there is an urgent demand for novel therapeutic approaches. MicroRNAs (miRNAs) are promising molecules to regulate gene expression in PDAC. This study investigates the role of miR-142 in cell proliferation and apoptosis in two cell lines, AsPC-1 and PANC-1, with a focus on gene expression changes of selected genes induced by overexpression of miR-142-5p. The molecular features in PDAC were evaluated using KEGG, and significant genes in cell cycle regulation, apoptosis, and PI3k/AKT pathway were selected (CDK6, MCL1, PIK3CA). DIANA-microT-CDS and TargetScan version 7.1 were used to select miR-142 based on prediction score. Selected genes did not contain any predicted seed site matches for the 3p arm of miR-142. miR-142 was overexpressed by transfecting a vector carrying the pre-miRNA-142 sequence into two pancreatic cancer cell lines. Overexpression of miR-142 and its effect on downregulating target genes was confirmed by quantitative real-time PCR (RT-qPCR). Predicted target genes (CDK6 and MCL1) were evaluated by the Luciferase assay. Apoptosis and cell cycle arrest were performed to analyze cell proliferation and cell viability under the effect of miR-142. Our results showed that miR-142-5p reduced the expression of its target genes. Cell cycle arrest was increased in both cell lines, while apoptosis increased in PANC-1. Overall, miR-142 may function as a tumor suppressor in PDAC by downregulating the overexpressed cancer-related genes and suppressing proliferation in AsPC-1 and PANC1.
- Open Access
Proteomic Analyses of the G Protein-Coupled Estrogen Receptor GPER1 Reveal Constitutive Links to Endoplasmic Reticulum, Glycosylation, Trafficking, and Calcium Signaling
The G protein-coupled estrogen receptor 1 (GPER1) has been proposed to mediate rapid responses to the steroid hormone estrogen. However, despite a strong interest in its potential role in cancer, whether it is indeed activated by estrogen and how this works remain controversial. To provide new tools to address these questions, we set out to determine the interactome of exogenously expressed GPER1. The combination of two orthogonal methods, namely APEX2-mediated proximity labeling and immunoprecipitation followed by mass spectrometry, gave us high-confidence results for 73 novel potential GPER1 interactors. We found that this GPER1 interactome is not affected by estrogen, a result that mirrors the constitutive activity of GPER1 in a functional assay with a Rac1 sensor. We specifically validated several hits highlighted by a gene ontology analysis. We demonstrate that CLPTM1 interacts with GPER1 and that PRKCSH and GANAB, the regulatory and catalytic subunits of α-glucosidase II, respectively, associate with CLPTM1 and potentially indirectly with GPER1. An imbalance in CLPTM1 levels induces nuclear association of GPER1, as does the overexpression of PRKCSH. Moreover, we show that the Ca2+ sensor STIM1 interacts with GPER1 and that upon STIM1 overexpression and depletion of Ca2+ stores, GPER1 becomes more nuclear. Thus, these new GPER1 interactors establish interesting connections with membrane protein maturation, trafficking, and calcium signaling.
Open AccessProteomic Analyses of the G Protein-Coupled Estrogen Receptor GPER1 Reveal Constitutive Links to Endoplasmic Reticulum, Glycosylation, Trafficking, and Calcium Signaling
The G protein-coupled estrogen receptor 1 (GPER1) has been proposed to mediate rapid responses to the steroid hormone estrogen. However, despite a strong interest in its potential role in cancer, whether it is indeed activated by estrogen and how this works remain controversial. To provide new tools to address these questions, we set out to determine the interactome of exogenously expressed GPER1. The combination of two orthogonal methods, namely APEX2-mediated proximity labeling and immunoprecipitation followed by mass spectrometry, gave us high-confidence results for 73 novel potential GPER1 interactors. We found that this GPER1 interactome is not affected by estrogen, a result that mirrors the constitutive activity of GPER1 in a functional assay with a Rac1 sensor. We specifically validated several hits highlighted by a gene ontology analysis. We demonstrate that CLPTM1 interacts with GPER1 and that PRKCSH and GANAB, the regulatory and catalytic subunits of α-glucosidase II, respectively, associate with CLPTM1 and potentially indirectly with GPER1. An imbalance in CLPTM1 levels induces nuclear association of GPER1, as does the overexpression of PRKCSH. Moreover, we show that the Ca2+ sensor STIM1 interacts with GPER1 and that upon STIM1 overexpression and depletion of Ca2+ stores, GPER1 becomes more nuclear. Thus, these new GPER1 interactors establish interesting connections with membrane protein maturation, trafficking, and calcium signaling.
- Open Access
- 28 September 2023
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 14 (3)
Silibinin Induces Apoptosis and G2/M Cell Cycle Arrest in Human Ovarian Cancer SKOV-3 Cell Line
Background: Silibinin, an herbal polyphenolic flavonolignan, has antioxidant and anticancer properties. Objectives: This study aimed to evaluate some cellular and molecular effects of silibinin on the human ovarian cancer SKOV-3 cell line. Methods: For cytotoxicity investigations of silibinin, MTT assay was used at 24, 48, and 72 hours. Apoptosis and cell cycle were studied by flow cytometry. The effect of silibinin on mRNA expression of B-cell lymphoma 2 (Bcl-2), cyclin E, and S-phase kinase-associated protein 2 (SKP2) was determined by Quantitative reverse transcription polymerase chain reaction (QRT-PCR). Results: Silibinin administration in lower concentrations (12.5 and 25 µg/mL) did not lead to significant (P < 0.05) changes in cell viability and even slightly increased cell growth after 72 hours. However, silibinin in higher concentrations (≥ 50µg/mL) inhibited SKOV-3 cell proliferation in a dose- and time-dependent manner. The mode of cell growth inhibition was apoptosis induction and G2/M cell cycle arrest. Silibinin caused down-regulation of the anti-apoptotic gene, namely Bcl-2. Additionally, silibinin resulted in down-regulation of the major genes in the cell cycle, including cyclin E and SKP2. Conclusions: Overall, this study confirmed the ability of silibinin to suppress ovarian cancer progression through the induction of apoptosis and inhibition of G2/M phase transition. Silibinin may be considered an efficient and safe herbal medication for ovarian cancer.
- 28 September 2023
- Published by Brieflands in Jentashapir Journal of Cellular and Molecular Biology
- Vol. 14 (3)
Open AccessSilibinin Induces Apoptosis and G2/M Cell Cycle Arrest in Human Ovarian Cancer SKOV-3 Cell Line
Background: Silibinin, an herbal polyphenolic flavonolignan, has antioxidant and anticancer properties. Objectives: This study aimed to evaluate some cellular and molecular effects of silibinin on the human ovarian cancer SKOV-3 cell line. Methods: For cytotoxicity investigations of silibinin, MTT assay was used at 24, 48, and 72 hours. Apoptosis and cell cycle were studied by flow cytometry. The effect of silibinin on mRNA expression of B-cell lymphoma 2 (Bcl-2), cyclin E, and S-phase kinase-associated protein 2 (SKP2) was determined by Quantitative reverse transcription polymerase chain reaction (QRT-PCR). Results: Silibinin administration in lower concentrations (12.5 and 25 µg/mL) did not lead to significant (P < 0.05) changes in cell viability and even slightly increased cell growth after 72 hours. However, silibinin in higher concentrations (≥ 50µg/mL) inhibited SKOV-3 cell proliferation in a dose- and time-dependent manner. The mode of cell growth inhibition was apoptosis induction and G2/M cell cycle arrest. Silibinin caused down-regulation of the anti-apoptotic gene, namely Bcl-2. Additionally, silibinin resulted in down-regulation of the major genes in the cell cycle, including cyclin E and SKP2. Conclusions: Overall, this study confirmed the ability of silibinin to suppress ovarian cancer progression through the induction of apoptosis and inhibition of G2/M phase transition. Silibinin may be considered an efficient and safe herbal medication for ovarian cancer.
- 11 March 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 65 (12) , 1979-1990
Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines
This study aimed to evaluate the comparative effect of silibinin (SB) on the expression of MiR‑20b and BCL2L11 in T47D and MCF-7 cell lines. Molecular simulation studies were carried out to analyze Erbb2, as a potential target of SB, to direct the breast cancer cells toward apoptosis. At first, cell viability, apoptosis, and cell cycle arrest-inducing capacity of SB were examined using MTT and flow cytometry analysis, respectively. Real-time PCR (RT-PCR) was employed to assess the effect of SB on BCL2L11, Phosphatase and tensin homolog (PTEN), and Caspase 9 mRNarrest-indu. Moreover, alterations in Caspase 9 protein expression were determined using Western blot analysis. Finally, AutoDockVina software was used to dock the SB/ MiR‑20b and SB/ erb-b2 receptor tyrosine kinase 2 (Erbb2) interaction. The obtained data revealed the potent cytotoxicity of SB in both T47D and MCF-7 cells through apoptosis induction and cell cycle arrest. SB-treated cells also showed downregulation of MiR‑20b and high expression of BCL2L11, PTEN, and Caspase 9 mRNA compared to non-treated cancer cells. Computational docking showed a strong interaction between SB/ MiR‑20b and SB/Erbb2. It can be concluded that SB had a strong anti-tumorigenic activity through BCL2L11upregulation and MiR‑20b down expression, maybe through targeting the PTEN and interacting with Erbb2, which resulted in apoptotic induction and cell cycle arrest.
- 11 March 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 65 (12) , 1979-1990
Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines
This study aimed to evaluate the comparative effect of silibinin (SB) on the expression of MiR‑20b and BCL2L11 in T47D and MCF-7 cell lines. Molecular simulation studies were carried out to analyze Erbb2, as a potential target of SB, to direct the breast cancer cells toward apoptosis. At first, cell viability, apoptosis, and cell cycle arrest-inducing capacity of SB were examined using MTT and flow cytometry analysis, respectively. Real-time PCR (RT-PCR) was employed to assess the effect of SB on BCL2L11, Phosphatase and tensin homolog (PTEN), and Caspase 9 mRNarrest-indu. Moreover, alterations in Caspase 9 protein expression were determined using Western blot analysis. Finally, AutoDockVina software was used to dock the SB/ MiR‑20b and SB/ erb-b2 receptor tyrosine kinase 2 (Erbb2) interaction. The obtained data revealed the potent cytotoxicity of SB in both T47D and MCF-7 cells through apoptosis induction and cell cycle arrest. SB-treated cells also showed downregulation of MiR‑20b and high expression of BCL2L11, PTEN, and Caspase 9 mRNA compared to non-treated cancer cells. Computational docking showed a strong interaction between SB/ MiR‑20b and SB/Erbb2. It can be concluded that SB had a strong anti-tumorigenic activity through BCL2L11upregulation and MiR‑20b down expression, maybe through targeting the PTEN and interacting with Erbb2, which resulted in apoptotic induction and cell cycle arrest.
- 13 January 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 65 (9) , 1444-1452
Evaluation of the Expression of miRNAs, LncRNAs, and their Target Gene, Caspase 3 in Glioblastoma Multiform: A Case–Control Study
Glioblastoma multiform (GBM) is an invasive cancer that causes high mortality in patients. Disruption of the apoptosis process is one of the main pathogenesis of the disease. Recently, LncRNAs and miRNAs have been shown to play an important role in the process of apoptosis. To follow the aim of study, 100 patients participated in the two groups of 50 individuals, including 50 GBM patients and 50 healthy individuals as the control group. Mononuclear cells were isolated from peripheral blood samples and RNA extraction was done. The expression changes of miR-17-5p, miR-20-5p, LINC01605, FAS-AS1, and Caspase 3 were examined using RT-PCR in both groups. Expression of LINC01605, miR-20-5p, and miR-17-5p increased in patients, while Caspase 3 and FAS-AS1 decreased; the difference was statistically significant between the two groups. In addition, it was found that these factors have the appropriate sensitivity and specificity as diagnostic markers. Finally, It is suggested to use the LINC01605, FAS-AS1, miR-20-5p, miR-17-5p, and Caspase 3 as apoptosis predictors in the GM patients.
- 13 January 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 65 (9) , 1444-1452
Evaluation of the Expression of miRNAs, LncRNAs, and their Target Gene, Caspase 3 in Glioblastoma Multiform: A Case–Control Study
Glioblastoma multiform (GBM) is an invasive cancer that causes high mortality in patients. Disruption of the apoptosis process is one of the main pathogenesis of the disease. Recently, LncRNAs and miRNAs have been shown to play an important role in the process of apoptosis. To follow the aim of study, 100 patients participated in the two groups of 50 individuals, including 50 GBM patients and 50 healthy individuals as the control group. Mononuclear cells were isolated from peripheral blood samples and RNA extraction was done. The expression changes of miR-17-5p, miR-20-5p, LINC01605, FAS-AS1, and Caspase 3 were examined using RT-PCR in both groups. Expression of LINC01605, miR-20-5p, and miR-17-5p increased in patients, while Caspase 3 and FAS-AS1 decreased; the difference was statistically significant between the two groups. In addition, it was found that these factors have the appropriate sensitivity and specificity as diagnostic markers. Finally, It is suggested to use the LINC01605, FAS-AS1, miR-20-5p, miR-17-5p, and Caspase 3 as apoptosis predictors in the GM patients.
- Open Access
- 27 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0276538
Carotenoids as potential inhibitors of TNFα in COVID-19 treatment
Tumor necrosis factor-alpha (TNF-α) is a multifunctional pro-inflammatory cytokine, responsible for autoimmune and inflammatory disorders. In COVID-19 patients, increased TNF-α concentration may provoke inflammatory cascade and induce the initiation of cytokine storm that may result in fatal pneumonia and acute respiratory distress syndrome (ADRS). Hence, TNFα is assumed to be a promising drug target against cytokine storm in COVID-19 patients. In the present study, we focused on finding novel small molecules that can directly block TNF-α-hTNFR1 (human TNF receptor 1) interaction. In this regards, TNF-α-inhibiting capacity of natural carotenoids was investigated in terms of blocking TNF-α-hTNFR1 interaction in COVID-19 patients with the help of a combination of in silico approaches, based on virtual screening, molecular docking, and molecular dynamics (MD) simulation. A total of 125 carotenoids were selected out of 1204 natural molecules, based on their pharmacokinetics properties and they all met Lipinski’s rule of five. Among them, Sorgomol, Strigol and Orobanchol had the most favorable ΔG with the best ADME (absorption, distribution, metabolism, excretion) properties, and were selected for MD simulation studies, which explored the complex stability and the impact of ligands on protein conformation. Our results showed that Sorgomol formed the most hydrogen bonds, resulting in the highest binding energy with lowest RMSD and RMSF, which made it the most appropriate candidate as TNF-α inhibitor. In conclusion, the present study could serve to expand possibilities to develop new therapeutic small molecules against TNF-α.
- 27 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0276538
Open AccessCarotenoids as potential inhibitors of TNFα in COVID-19 treatment
Tumor necrosis factor-alpha (TNF-α) is a multifunctional pro-inflammatory cytokine, responsible for autoimmune and inflammatory disorders. In COVID-19 patients, increased TNF-α concentration may provoke inflammatory cascade and induce the initiation of cytokine storm that may result in fatal pneumonia and acute respiratory distress syndrome (ADRS). Hence, TNFα is assumed to be a promising drug target against cytokine storm in COVID-19 patients. In the present study, we focused on finding novel small molecules that can directly block TNF-α-hTNFR1 (human TNF receptor 1) interaction. In this regards, TNF-α-inhibiting capacity of natural carotenoids was investigated in terms of blocking TNF-α-hTNFR1 interaction in COVID-19 patients with the help of a combination of in silico approaches, based on virtual screening, molecular docking, and molecular dynamics (MD) simulation. A total of 125 carotenoids were selected out of 1204 natural molecules, based on their pharmacokinetics properties and they all met Lipinski’s rule of five. Among them, Sorgomol, Strigol and Orobanchol had the most favorable ΔG with the best ADME (absorption, distribution, metabolism, excretion) properties, and were selected for MD simulation studies, which explored the complex stability and the impact of ligands on protein conformation. Our results showed that Sorgomol formed the most hydrogen bonds, resulting in the highest binding energy with lowest RMSD and RMSF, which made it the most appropriate candidate as TNF-α inhibitor. In conclusion, the present study could serve to expand possibilities to develop new therapeutic small molecules against TNF-α.
- Open Access
- 21 November 2022
- Published by Wiley in Cancer Reports
- Vol. 6 (3)
Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients
Background and Aim: Chronic lymphocytic leukemia (CLL) is a monoclonal malignancy of B lymphocytes. Since common mutations in NOTCH1 and SF3B1, along with other possible chromosomal alterations, change disease severity and survival of patients with CLL, we aimed to evaluate the correlation of common mutations in NOTCH1 and SF3B1 as the poor prognostic markers with chromosomal abnormalities and clinical hematology.Method: This retrospective study was performed on the peripheral blood of 51 patients diagnosed before chemotherapy with CLL. G‐banding karyotype and FISH were performed. For NOTCH1, exon 34 and for SF3B1, exons 14,15,16 were assessed using Sanger sequencing.Results: The mutation frequency of NOTCH1 and SF3B1 with the pathogenic clinical status was 6:51 (11.76%), and variants obtained from both genes were 9:51 (17.64%). The frequency of SF3B1 mutation (K666E) was higher than in previous studies (p‐value <.05). There was a significant correlation between NOTCH1 mutations and del17p13 (p‐value = .068), also SF3B1 mutations with del11q22 (p‐value = .095) and del13q14 (p‐value = .066). Up to 90% of the specific stimuli used for the G‐banding karyotype successfully identified the malignant clone. There was a significant relationship between the cluster of differentiation 38 (CD38) expression level and NOTCH1 mutations (p‐value = .019) and a significant correlation between Binet classification and the SF3B1 (p‐value = .096).Conclusion: The correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities and CD38 expression may reveal the overall patient's survival rate. The mutations may be effective in the clonal expansion and progression of CLL, particularly in the diagnosis stage, as well as the control and management of the treatment.
- 21 November 2022
- Published by Wiley in Cancer Reports
- Vol. 6 (3)
Open AccessPrognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients
Background and Aim: Chronic lymphocytic leukemia (CLL) is a monoclonal malignancy of B lymphocytes. Since common mutations in NOTCH1 and SF3B1, along with other possible chromosomal alterations, change disease severity and survival of patients with CLL, we aimed to evaluate the correlation of common mutations in NOTCH1 and SF3B1 as the poor prognostic markers with chromosomal abnormalities and clinical hematology.Method: This retrospective study was performed on the peripheral blood of 51 patients diagnosed before chemotherapy with CLL. G‐banding karyotype and FISH were performed. For NOTCH1, exon 34 and for SF3B1, exons 14,15,16 were assessed using Sanger sequencing.Results: The mutation frequency of NOTCH1 and SF3B1 with the pathogenic clinical status was 6:51 (11.76%), and variants obtained from both genes were 9:51 (17.64%). The frequency of SF3B1 mutation (K666E) was higher than in previous studies (p‐value <.05). There was a significant correlation between NOTCH1 mutations and del17p13 (p‐value = .068), also SF3B1 mutations with del11q22 (p‐value = .095) and del13q14 (p‐value = .066). Up to 90% of the specific stimuli used for the G‐banding karyotype successfully identified the malignant clone. There was a significant relationship between the cluster of differentiation 38 (CD38) expression level and NOTCH1 mutations (p‐value = .019) and a significant correlation between Binet classification and the SF3B1 (p‐value = .096).Conclusion: The correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities and CD38 expression may reveal the overall patient's survival rate. The mutations may be effective in the clonal expansion and progression of CLL, particularly in the diagnosis stage, as well as the control and management of the treatment.
- Open Access
- 10 June 2022
- Published by Springer Nature in Research Square
Silibinin affects transcription factors of cell cycle, apoptosis, angiogenesis and metastasis in breast cancer mice model: Targeting the hallmarks of cancer
Silibinin is a phyto-flavonoid compound and has been reported to exert anticancer effects on several tumors, including breast cancer. The present study exploited Flow cytometry, H&E staining, immunofluorescence (IF), and RT-PCR to extensively observe the effect of silibinin on the expression of cell-cycle and apoptosis-related transcription factors and genes in mice breast cancer cells 4T1. culture of 4T1 cell, MTT, flow cytometry, hematoxylin and eosin stains, immunofluorescent and Real Time PCR experiments were performed. silibinin caused a significant cytotoxicity, induction of apoptosis and cell cycle arrest in 4T1 cells, in vitro and in vivo. CD31 and HmgB1 expression showed a considerable decline. Evaluation of gene expression showed a marked decrease in Bcl-2, FoxC2, HoxB9, and FoxM1 genes, while a significant increase in TP53, P21, Bax, FoxF1, and HmgB1. Silibinin indicates the impact on inducing apoptosis by lower expression of Bcl-2, higher expression of Bax and TP53. While increased expression of P21 is thought to cause cell cycle arrest. In the meanwhile, under-expression of HoxB9, FoxC2, and FoxM1 and over-expression of FoxF1 caused restricted EMT, metastasis, angiogenesis and invasion in cancer.
- 10 June 2022
- Published by Springer Nature in Research Square
Open AccessSilibinin affects transcription factors of cell cycle, apoptosis, angiogenesis and metastasis in breast cancer mice model: Targeting the hallmarks of cancer
Silibinin is a phyto-flavonoid compound and has been reported to exert anticancer effects on several tumors, including breast cancer. The present study exploited Flow cytometry, H&E staining, immunofluorescence (IF), and RT-PCR to extensively observe the effect of silibinin on the expression of cell-cycle and apoptosis-related transcription factors and genes in mice breast cancer cells 4T1. culture of 4T1 cell, MTT, flow cytometry, hematoxylin and eosin stains, immunofluorescent and Real Time PCR experiments were performed. silibinin caused a significant cytotoxicity, induction of apoptosis and cell cycle arrest in 4T1 cells, in vitro and in vivo. CD31 and HmgB1 expression showed a considerable decline. Evaluation of gene expression showed a marked decrease in Bcl-2, FoxC2, HoxB9, and FoxM1 genes, while a significant increase in TP53, P21, Bax, FoxF1, and HmgB1. Silibinin indicates the impact on inducing apoptosis by lower expression of Bcl-2, higher expression of Bax and TP53. While increased expression of P21 is thought to cause cell cycle arrest. In the meanwhile, under-expression of HoxB9, FoxC2, and FoxM1 and over-expression of FoxF1 caused restricted EMT, metastasis, angiogenesis and invasion in cancer.
- Open Access
- 1 June 2019
- Vol. 21 (2) , 124-134
Histone Modification Marks Strongly Regulate CDH1 Promoter in Prostospheres as A Model of Prostate Cancer Stem Like Cells
Cadherin-1 (CDH1) plays an important role in the metastasis, while expression of this protein is under control of epigenetic changes on its gene promoter. Therefore we evaluated both DNA methylation (DNAmet) and histone modification marks of CDH1 in prostate cancer stem like cells (PCSLCs). In this experimental study, we isolated PCSLCs using cell surface marker and prostaspheroid formation, respectively. The cells isolated from both methods were characterized and then the levels of H3K4me2, H3K27me3, H3K9me2/3 and H3K9ac as well as DNAmet were assessed in CDH1 promoter of the isolated cells. The CD44+ CD49hi cells were not validated as PCSLCs. However, prostaspheres overexpressed stemness related genes and had higher ability of invasion potential, associated with reduction in CDH1 expression. Epigenetic status analysis showed that CDH1 promoter was hypo-methylated. Histone modifications of H3K9ac and H3K4me3 were significantly reduced, in parallel with an increased level of H3K27me3. Our results suggest that slight decrease of DNAmet of the CpG island in CDH1 promoter does not significantly contribute to the change of CDH1 expression. Therefore, histone modifications are responsible in repressing CDH1 in PCSLCs.
- 1 June 2019
- Vol. 21 (2) , 124-134
Open AccessHistone Modification Marks Strongly Regulate CDH1 Promoter in Prostospheres as A Model of Prostate Cancer Stem Like Cells
Cadherin-1 (CDH1) plays an important role in the metastasis, while expression of this protein is under control of epigenetic changes on its gene promoter. Therefore we evaluated both DNA methylation (DNAmet) and histone modification marks of CDH1 in prostate cancer stem like cells (PCSLCs). In this experimental study, we isolated PCSLCs using cell surface marker and prostaspheroid formation, respectively. The cells isolated from both methods were characterized and then the levels of H3K4me2, H3K27me3, H3K9me2/3 and H3K9ac as well as DNAmet were assessed in CDH1 promoter of the isolated cells. The CD44+ CD49hi cells were not validated as PCSLCs. However, prostaspheres overexpressed stemness related genes and had higher ability of invasion potential, associated with reduction in CDH1 expression. Epigenetic status analysis showed that CDH1 promoter was hypo-methylated. Histone modifications of H3K9ac and H3K4me3 were significantly reduced, in parallel with an increased level of H3K27me3. Our results suggest that slight decrease of DNAmet of the CpG island in CDH1 promoter does not significantly contribute to the change of CDH1 expression. Therefore, histone modifications are responsible in repressing CDH1 in PCSLCs.